Published By : 07 Jun 2016 | Published By : QYRESEARCH
Oral contraceptive pills, also called combined pills or combined contraceptive pills are a convenient and effective mode of birth control are widely used by women across the globe. Many varieties of oral contraceptives are available in the market, deferring according to the dosage option: packs of 21 days, 24 days, 28 days, and 91 days, and the four-phase packs.
The products Seasonable’, manufactured by Barr Laboratories, and Seasonique, manufactured by Teva Pharmaceutical Industries are some of the most popular product types in the market. The product Natazia, produced by Bayer AG is the leading product type in the four-phase segment while the products Loestrin and Yaz are highly popular in the 24-day pack segment. Many other international pharmaceutical giants, such as Merck & Co., Inc., Allergan, plc, Mankind Pharma Ltd., Piramal Enterprises Ltd., and Pfizer, Inc., also have their products in the oral contraceptive pills market.
The market for oral contraceptive pills is driven by the continuous rise in the number of new options in the market. The pharmaceutical company Lupin Ltd. has launched nine new products in the U.S. and has formerly received approval for its 21 contraceptives from the U.S. FDA. The company has only recently (start of the year) received approval for new contraceptive pills in the U.S. Owing to the high demand for oral contraceptive pills in the country, companies like Lupin are expected to register appreciable sales in the American market.
Lupin, which has only one contender in the American market when it comes to generic versions of oral contraceptive pills, has reportedly launched over 35 contraceptive pills in the American market till date. With many other companies introducing their products in the market at a steady pace, the oral contraceptives market is expected to witness significant growth in the coming years as consumers will have more choices.
Across the globe, especially in several developing as well as under-developed countries, many government and non-profit organizations make contraceptive pills available as a way of improving women’s health and keeping population growth in check. These factors also provide a major push to the market.